burn
Conditions
Interventions
experimental group:allogeneic MEEK skin transplantation
control group:none
Sponsors
the 990th Hospital of the Joint Logistics Support Force
Eligibility
Sex/Gender
All
Age
1 Years to 65 Years
Inclusion criteria
Inclusion criteria: Patient inclusion criteria: (Before the experiment, patients must meet all the requirements under the item in order to be included) 1) Age 1-65 years old, gender not limited 2) Burn area greater than 50% when over 14 years old; When the patient is under 14 years old, the burn area is greater than 30%, and there are deep burns in functional areas such as the face, neck, hands, and joints 3) The patient needs to use split-thick skin grafts to repair burn wounds in their functional areas 4) Agree to participate in this experiment and sign the informed consent form 5) No hepatitis A, hepatitis B, AIDS, tuberculosis and other infectious diseases in active period Donor inclusion criteria: (Before the experiment, the donor must meet all the requirements under the item in order to be included) 1) Aged 18-65 years old, regardless of gender, relatives of patients (parents, children, brothers and sisters, etc.) 2) Agree to participate in this experiment and sign the informed consent form 3) No hepatitis A, hepatitis B, AIDS, tuberculosis and other infectious diseases
Exclusion criteria
Exclusion criteria: Exclusion criteria for patients: (Before the experiment, patients who meet any of the requirements under this item cannot be included in the group) 1) Severe wound infection 2) Individuals with severe organic lesions such as the heart, brain, liver, kidneys, and lungs 3) Individuals with severe mental illness and potential resistance risk 4) Systemic degenerative diseases, such as malignant tumors, etc 5) Pregnant women 6) Individuals with a history of severe allergies or poor compliance 7) Researchers believe that disease patients who are not suitable to participate in this clinical trial Exclusion criteria for donors: (Prior to the experiment, if a donor meets any of the requirements under this item, they cannot be included in the group) 1) Individuals with severe organic lesions such as the heart, brain, liver, kidneys, and lungs 2) Individuals with severe mental illness and potential resistance risk 3) Systemic degenerative diseases, such as malignant tumors, etc 4) Pregnant women 5) Individuals with a history of severe allergies or poor compliance 6) Researchers believe that people with disease that are not suitable to participate in this clinical trial
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| wound healing time;Number of skin donations;Healing time of the donor area; | — |
Secondary
| Measure | Time frame |
|---|---|
| Number of implant procedures;Keloidal hyperplasia;wound infection;Length of stay;Inpatient costs;complication; | — |
Countries
China
Contacts
Public ContactZhichen Lin
the 990th Hospital of the Joint Logistics Support Force
Outcome results
None listed